Skip to content
Find a Provider
Jason Mendler, M.D., Ph.D.

Jason Mendler, M.D., Ph.D.

Hematology & Oncology , Cancer

4.9 out of 5 stars
308 Ratings
47 Comments
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-5823
Fax (585) 273-1051

About Me

I chose oncology because of its richness and the ability to impact people's lives in a positive way. The field is unmatched in terms of the interpersonal relationships that are developed, medical complexity and research opportunities.

My philosophy is that optimal patient care stems from both...
I chose oncology because of its richness and the ability to impact people's lives in a positive way. The field is unmatched in terms of the interpersonal relationships that are developed, medical complexity and research opportunities.

My philosophy is that optimal patient care stems from both a thorough understanding of the disease process, as well as intimate knowledge of the patient as a human being. I continually work to deepen my relationships with patients in order to improve outcomes.

I am a regular person who is as comfortable coaching my kids' sports teams as I am with a stethoscope around my neck. I love spending time with my family, which includes my wife Ticia and children Caleb, Ava and Megan. My area of expertise includes myeloid leukemias.

Conditions I Treat

- Acute leukemia, all types
- Chronic myeloid leukemia
- Myelodysplastic syndrome
- Myeloproliferative disorders including polycythemia vera, myelofibrosis and essential thrombocythemia

Faculty Appointments

Professor - Department of Medicine, Hematology/Oncology (SMD)

Professor - Cancer Center - Joint

Credentials

Residency & Fellowship

Fellowship, Medical Oncology, Ohio State University Wexner Medical Center. 2009 - 2011

Residency, Internal Medicine, University of Rochester Medical Center. 2006 - 2008

Internship, Internal Medicine, University of Rochester Medical Center. 2005 - 2006

Education

MD | University of Rochester School of Medicine/Dentistry (USA). 2005

PhD | University of Rochester School of Medicine/Dentistry (USA). 2004

Awards

James 14th Annual Scientific Meeting award for one of top 3 Translational Research Poster. 2012

James V. Warren Award for accomplishments as the most outstanding research fellow in the Department of Internal Medicine. 2011

ASH news daily author. 2010

Distinction in research, Internal Medicine Residency Program. 2008

Raphael Dolin Resident Research Award for dedication to patient care, critical scholarship, and teaching. 2008

Rochester city-wide Internal Medicine resident poster day 1st place, scientific division. 2007

Class of 1990 Resident Teaching Award. 2007

: University of Rochester School of Medicine Class of 1976 Prize (In. 2005

Arnold P. Gold Foundation 2004 Humanism in Medicine Essay contest-2nd prize. 2004

Alpha Omega Alpha. 2004

Phi Beta Kappa. 1997

Summa Cum Laude. 1997

Publications

Journal Articles

Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid leukemia and their caregivers: UR-GOAL 3.

Loh KP, Ng QMR, Mohile SG, Norton S, Epstein RM, Sohn MB, Richardson D, Jamy O, Hedjri SM, Blumberg R, Nafis L, Jensen-Battaglia M, Wang Y, Mendler J, Liesveld J, Huselton EJ, Rodenbach R, Moore J, Maguire C, Buechler SM, Hodges S, Klepin HD

Journal of geriatric oncology.. 2025 January 18 :102187. Epub 01/18/2025.

Clinicians' Perspectives on the Telehealth Serious Illness Care Program for Older Adults With Myeloid Malignancies: Single-Arm Pilot Study.

LoCastro M, Wang Y, Yu T, Mortaz-Hedjri S, Mendler J, Norton S, Bernacki R, Carroll T, Klepin H, Wedow L, Goonan S, Erdos H, Bagnato B, Liesveld J, Huselton E, Kluger B, Loh KP

JMIR formative research.. 2024 June 278 :e58503. Epub 06/27/2024.

Patient-oncologist discussion of treatment decisions: Exploring the role of a patient-centered communication tool for older adults with acute myeloid leukemia and their caregivers.

Jensen-Battaglia M, LoCastro M, Oh H, Sanapala C, Flannery M, Mendler JH, Liesveld J, Huselton E, Loh KP

Journal of geriatric oncology.. 2024 June 15 (5):101716. Epub 02/09/2024.

Exploring the role of the oncologist in promoting shared decision making during treatment planning for older adults with acute myeloid leukemia.

LoCastro M, Jensen-Battaglia M, Sanapala C, Rodenbach R, Mendler JH, Liesveld J, Huselton E, Loh KP

Journal of geriatric oncology.. 2024 June 15 (5):101793. Epub 05/11/2024.

Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study.

LoCastro M, Wang Y, Sanapala C, Jensen-Battaglia M, Wittink M, Norton S, Klepin HD, Richardson DR, Mendler JH, Liesveld J, Huselton E, Loh KP

Journal of geriatric oncology.. 2023 June 14 (5):101529. Epub 05/25/2023.

Exercise and epigenetic ages in older adults with myeloid malignancies.

Loh KP, Sanapala C, Jensen-Battaglia M, Rana A, Sohn MB, Watson E, Gilmore N, Klepin HD, Mendler JH, Liesveld J, Huselton E, LoCastro M, Susiarjo M, Netherby-Winslow C, Williams AM, Mustian K, Vertino P, Janelsins MC

European journal of medical research.. 2023 May 3028 (1):180. Epub 05/30/2023.

Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.

Locastro M, Sanapala C, Mendler JH, Norton SA, Bernacki R, Carroll T, Klepin HD, Watson EE, Liesveld JL, Huselton EJ, O'Dwyer KM, Baran AM, Flannery M, Kluger B, Loh KP

Blood advances.. 2023 May 97 (9):1871-1884. Epub 1900 01 01.

Myelodysplastic syndromes disable human CD271+VCAM1+CD146+ niches supporting normal hematopoietic stem/progenitor cells.

Kawano Y, Kawano H, Ghoneim D, Fountaine TJ, Byun DK, LaMere MW, Mendler JH, Ho T, Salama NA, Myers JR, Hussein SE, Frisch BJ, Ashton JM, Azadniv M, Liesveld JL, Kfoury Y, Scadden DT, Becker MW, Calvi LM

bioRxiv : the preprint server for biology.. 2023 April 28 Epub 04/28/2023.

Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study.

LoCastro M, Sanapala C, Wang Y, Jensen-Battaglia M, Wittink M, Norton S, Klepin HD, Richardson DR, Mendler JH, Liesveld J, Huselton E, O'Dwyer K, Cortes AM, Rodriguez C, Dale W, Loh KP

Cancer medicine. 2023 April 12 (7):8581-8593. Epub 12/19/2022.

Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes.

LoCastro M, Sanapala C, Mendler JH, Norton S, Bernacki R, Carroll T, Klepin H, Watson E, Liesveld J, Huselton E, O'Dwyer K, Baran A, Flannery M, Kluger BM, Loh KP

Journal of geriatric oncology.. 2023 January 14 (1):101374. Epub 09/10/2022.

Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia.

Manogna D, Lipof JJ, Baran AM, Said B, Becker MW, Mendler JH, Aljitawi OS, O'Dwyer KM, Huselton E, Burack R, Blaney M, Liesveld JL, Loh KP

Journal of geriatric oncology.. 2023 January 14 (1):101403. Epub 11/10/2022.

Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist.

Watson EE, Sanapala C, Cortes AM, Klepin HD, Wittink M, Norton SA, Richardson DR, Dale W, Magnuson A, Mendler JH, Liesveld JL, Huselton EJ, O'Dwyer KM, LeBlanc TW, El-Jawahri A, Wong M, Loh KP

Blood advances.. 2022 November 86 (21):5707-5710. Epub 1900 01 01.

Older patients' experiences following initial diagnosis of acute myeloid leukemia: A qualitative study.

Abdallah M, Kadambi S, Parsi M, Rai M, Mendler JH, Wittink M, Duberstein PR, Tsang M, Klepin HD, Loh KP

Journal of geriatric oncology.. 2022 November 13 (8):1230-1235. Epub 09/03/2022.

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.

Moyo TK, Mendler JH, Itzykson R, Kishtagari A, Solary E, Seegmiller AC, Gerds AT, Ayers GD, Dezern AE, Nazha A, Valent P, van de Loosdrecht AA, Onida F, Pleyer L, Cirici BX, Tibes R, Geissler K, Komrokji RS, Zhang J, Germing U, Steensma DP, Wiseman DH, Pfeilstöecker M, Elena C, Cross NCP, Kiladjian JJ, Luebbert M, Mesa RA, Montalban-Bravo G, Sanz GF, Platzbecker U, Patnaik MM, Padron E, Santini V, Fenaux P, Savona MR,

BMC cancer.. 2022 September 2422 (1):1013. Epub 09/24/2022.

How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia.

Moore JW, Torres N, Superdock M, Mendler JH, Loh KP

Current treatment options in oncology.. 2022 August 23 (8):1086-1103. Epub 06/10/2022.

A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms.

Loh KP, Sanapala C, Watson EE, Jensen-Battaglia M, Janelsins MC, Klepin HD, Schnall R, Culakova E, Vertino P, Susiarjo M, Lin PJ, Mendler JH, Liesveld JL, Huselton EJ, Taberner K, Mohile SG, Mustian K

Blood advances.. 2022 July 126 (13):3850-3860. Epub 1900 01 01.

Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2).

Loh KP, Sanapala C, Janelsins M, Klepin HD, Schnall R, Culakova E, Sohn MB, Vertino P, Susiarjo M, Jensen-Battaglia M, Becker MW, Liesveld J, Mendler JH, Huselton E, Lin PJ, Mustian K

Journal of geriatric oncology.. 2022 May 13 (4):545-553. Epub 12/21/2021.

A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.

Liesveld JL, Baran A, Azadniv M, Misch H, Nedrow K, Becker M, Loh KP, O'Dwyer KM, Mendler JH

Leukemia research.. 2022 January 112 :106749. Epub 11/11/2021.

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes.

Locastro M, Baran A, Liesveld JL, Huselton EJ, Becker MW, O'Dwyer KM, Aljitawi OS, Baumgart M, Snyder E, Kluger B, Loh KP, Mendler JH

Blood advances.. 2021 December 285 (24):5554-5564. Epub 1900 01 01.

Developing and adapting a mobile health exercise intervention for older patients with myeloid neoplasms: A qualitative study.

Loh KP, Sanapala C, Di Giovanni G, Klepin HD, Janelsins M, Schnall R, Culakova E, Vertino P, Susiarjo M, Mendler JH, Liesveld JL, Lin PJ, Dunne RF, Kleckner I, Mustian K, Mohile SG

Journal of geriatric oncology.. 2021 July 12 (6):909-914. Epub 03/04/2021.

Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.

Loh KP, Abdallah M, Kadambi S, Wells M, Kumar AJ, Mendler JH, Liesveld JL, Wittink M, O'Dwyer K, Becker MW, McHugh C, Stock W, Majhail NS, Wildes TM, Duberstein P, Mohile SG, Klepin HD

Leukemia & lymphoma.. 2021 February 62 (2):387-398. Epub 10/11/2020.

Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.

Flannelly C, Tan BE, Tan JL, McHugh CM, Sanapala C, Lagu T, Liesveld JL, Aljitawi O, Becker MW, Mendler JH, Klepin HD, Stock W, Wildes TM, Artz A, Majhail NS, Loh KP

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2020 December 26 (12):2335-2345. Epub 09/20/2020.

Remission of anti-TIF1? dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.

Bawany F, Tbakhi B, Mendler JH, Richardson CT, Bennett JM, Aljitawi OS

Blood advances.. 2020 November 244 (22):5698-5701. Epub 1900 01 01.

Management of Acute Myeloid Leukemia (AML) in Older Patients.

Abdallah M, Xie Z, Ready A, Manogna D, Mendler JH, Loh KP

Current oncology reports.. 2020 July 2822 (10):103. Epub 07/28/2020.

Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia.

Guo N, Azadniv M, Coppage M, Nemer M, Mendler J, Becker M, Liesveld J

Translational oncology.. 2019 April 12 (4):602-613. Epub 01/27/2019.

Novel mHealth App to Deliver Geriatric Assessment-Driven Interventions for Older Adults With Cancer: Pilot Feasibility and Usability Study.

Loh KP, Ramsdale E, Culakova E, Mendler JH, Liesveld JL, O'Dwyer KM, McHugh C, Gilles M, Lloyd T, Goodman M, Klepin HD, Mustian KM, Schnall R, Mohile SG

JMIR cancer.. 2018 October 294 (2):e10296. Epub 10/29/2018.

ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.

Sahai T, Henrichs K, Refaai M, Heal JM, Kirkley SA, Schmidt AE, Mendler JH, Masel D, Liesveld J, Aquina C, Blumberg N

Leukemia research.. 2017 November 62 :1-3. Epub 09/23/2017.

Index case of acute myeloid leukemia in a family harboring a novel germ line mutation.

Ram J, Flamm G, Balys M, Sivagnanalingam U, Rothberg PG, Iqbal A, Myers JR, Corbett A, Ashton JM, Mendler JH

Blood advances.. 2017 March 141 (8):500-503. Epub 03/14/2017.

Improved outcomes in acute myeloid leukemia patients treated with washed transfusions.

Greener D, Henrichs KF, Liesveld JL, Heal JM, Aquina CT, Phillips GL, Kirkley SA, Milner LA, Refaai MA, Mendler JH, Szydlowski J, Masel D, Schmidt A, Boscoe FP, Schymura MJ, Blumberg N

American journal of hematology.. 2017 January 92 (1):E8-E9. Epub 1900 01 01.

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.

Ho TC, LaMere M, Stevens BM, Ashton JM, Myers JR, O'Dwyer KM, Liesveld JL, Mendler JH, Guzman M, Morrissette JD, Zhao J, Wang ES, Wetzler M, Jordan CT, Becker MW

Blood.. 2016 September 29128 (13):1671-8. Epub 07/15/2016.

Spontaneous Remission in an Older Patient with Relapsed ITD Mutant AML.

Vachhani P, Mendler JH, Evans A, Deeb G, Starostik P, Wallace PK, Wang ES

Case reports in hematology.. 2016 2016 :1259759. Epub 12/29/2016.

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.

Khalife J, Radomska HS, Santhanam R, Huang X, Neviani P, Saultz J, Wang H, Wu YZ, Alachkar H, Anghelina M, Dorrance A, Curfman J, Bloomfield CD, Medeiros BC, Perrotti D, Lee LJ, Lee RJ, Caligiuri MA, Pichiorri F, Croce CM, Garzon R, Guzman ML, Mendler JH, Marcucci G

Leukemia.. 2015 October 29 (10):1981-92. Epub 05/14/2015.

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.

Niederwieser C, Kohlschmidt J, Volinia S, Whitman SP, Metzeler KH, Eisfeld AK, Maharry K, Yan P, Frankhouser D, Becker H, Schwind S, Carroll AJ, Nicolet D, Mendler JH, Curfman JP, Wu YZ, Baer MR, Powell BL, Kolitz JE, Moore JO, Carter TH, Bundschuh R, Larson RA, Stone RM, Mrózek K, Marcucci G, Bloomfield CD

Leukemia.. 2015 March 29 (3):567-75. Epub 09/10/2014.

Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia.

Sivagnanalingam U, Balys M, Eberhardt A, Wang N, Myers JR, Ashton JM, Becker MW, Calvi LM, Mendler JH

PloS one.. 2015 10 (7):e0132375. Epub 07/15/2015.

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.

Becker H, Maharry K, Mrózek K, Volinia S, Eisfeld AK, Radmacher MD, Kohlschmidt J, Metzeler KH, Schwind S, Whitman SP, Mendler JH, Wu YZ, Nicolet D, Paschka P, Powell BL, Carter TH, Wetzler M, Kolitz JE, Carroll AJ, Baer MR, Caligiuri MA, Stone RM, Marcucci G, Bloomfield CD

Leukemia.. 2014 August 28 (8):1754-1758. Epub 03/21/2014.

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy.

Whitman SP, Kohlschmidt J, Maharry K, Volinia S, Mrózek K, Nicolet D, Schwind S, Becker H, Metzeler KH, Mendler JH, Eisfeld AK, Carroll AJ, Powell BL, Carter TH, Baer MR, Kolitz JE, Park IK, Stone RM, Caligiuri MA, Marcucci G, Bloomfield CD

Leukemia.. 2014 June 28 (6):1252-1258. Epub 12/11/2013.

SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.

Alachkar H, Santhanam R, Maharry K, Metzeler KH, Huang X, Kohlschmidt J, Mendler JH, Benito JM, Hickey C, Neviani P, Dorrance AM, Anghelina M, Khalife J, Tarighat SS, Volinia S, Whitman SP, Paschka P, Hoellerbauer P, Wu YZ, Han L, Bolon BN, Blum W, Mrózek K, Carroll AJ, Perrotti D, Andreeff M, Caligiuri MA, Konopleva M, Garzon R, Bloomfield CD, Marcucci G

The Journal of clinical investigation.. 2014 April 124 (4):1512-24. Epub 03/03/2014.

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.

Marcucci G, Yan P, Maharry K, Frankhouser D, Nicolet D, Metzeler KH, Kohlschmidt J, Mrózek K, Wu YZ, Bucci D, Curfman JP, Whitman SP, Eisfeld AK, Mendler JH, Schwind S, Becker H, Bär C, Carroll AJ, Baer MR, Wetzler M, Carter TH, Powell BL, Kolitz JE, Byrd JC, Plass C, Garzon R, Caligiuri MA, Stone RM, Volinia S, Bundschuh R, Bloomfield CD

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 February 2032 (6):548-56. Epub 12/30/2013.

Reply to "rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases". Haematologica 2014;99(2):e20-21.

Mendler JH, Marcucci G, Bloomfield CD

Haematologica.. 2014 February 99 (2):e22. Epub 1900 01 01.

Extracellular crystals in plasma cell myeloma.

Brown JT, Burack WR, Becker MW, Vlad-Vonica R, Nadasdy T, Bennett JM, Mendler JH

Leukemia research reports.. 2014 3 (2):49-50. Epub 06/18/2014.

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.

Metzeler KH, Maharry K, Kohlschmidt J, Volinia S, Mrózek K, Becker H, Nicolet D, Whitman SP, Mendler JH, Schwind S, Eisfeld AK, Wu YZ, Powell BL, Carter TH, Wetzler M, Kolitz JE, Baer MR, Carroll AJ, Stone RM, Caligiuri MA, Marcucci G, Bloomfield CD

Leukemia.. 2013 October 27 (10):2023-31. Epub 06/14/2013.

In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline.

Mendler JH, Maharry K, Becker H, Eisfeld AK, Senter L, Mrózek K, Kohlschmidt J, Metzeler KH, Schwind S, Whitman SP, Khalife J, Caligiuri MA, Klisovic RB, Moore JO, Carter TH, Marcucci G, Bloomfield CD

Haematologica.. 2013 August 98 (8):e92-4. Epub 06/10/2013.

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.

Marcucci G, Maharry KS, Metzeler KH, Volinia S, Wu YZ, Mrózek K, Nicolet D, Kohlschmidt J, Whitman SP, Mendler JH, Schwind S, Becker H, Eisfeld AK, Carroll AJ, Powell BL, Kolitz JE, Garzon R, Caligiuri MA, Stone RM, Bloomfield CD

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 June 1031 (17):2086-93. Epub 05/06/2013.

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.

Mendler JH, Maharry K, Radmacher MD, Mrózek K, Becker H, Metzeler KH, Schwind S, Whitman SP, Khalife J, Kohlschmidt J, Nicolet D, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2012 September 130 (25):3109-18. Epub 07/02/2012.

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.

Eisfeld AK, Marcucci G, Maharry K, Schwind S, Radmacher MD, Nicolet D, Becker H, Mrózek K, Whitman SP, Metzeler KH, Mendler JH, Wu YZ, Liyanarachchi S, Patel R, Baer MR, Powell BL, Carter TH, Moore JO, Kolitz JE, Wetzler M, Caligiuri MA, Larson RA, Tanner SM, de la Chapelle A, Bloomfield CD

Blood.. 2012 July 12120 (2):249-58. Epub 04/23/2012.

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia.

Whitman SP, Caligiuri MA, Maharry K, Radmacher MD, Kohlschmidt J, Becker H, Mrózek K, Wu YZ, Schwind S, Metzeler KH, Mendler JH, Wen J, Baer MR, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Larson RA, Marcucci G, Bloomfield CD

Leukemia.. 2012 July 26 (7):1713-7. Epub 02/07/2012.

Salvage therapy in Hodgkin's lymphoma.

Mendler JH, Friedberg JW

The oncologist.. 2009 April 14 (4):425-32. Epub 04/02/2009.

Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.

Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW

Annals of oncology : official journal of the European Society for Medical Oncology. 2008 October 19 (10):1759-64. Epub 05/25/2008.

A medical experience that taught me about humanism in medicine.

Mendler J

Academic medicine : journal of the Association of American Medical Colleges.. 2005 November 80 (11):1066. Epub 1900 01 01.

TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point.

Lissy NA, Van Dyk LF, Becker-Hapak M, Vocero-Akbani A, Mendler JH, Dowdy SF

Immunity.. 1998 January 8 (1):57-65. Epub 1900 01 01.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.9 stars

Likelihood of recommending this care provider to others

4.9 stars

Explanations the care provider gave you about your problem or condition

4.9 stars

Care provider's efforts to include you in decisions about your care

4.9 stars

Concern the care provider showed for your questions or worries

4.9 stars

Patient Comments

5.0 stars

Dr. Mendler always explains what is going on with my condition and really listens to my concerns.

Feb 12, 2025

4.8 stars

I think Dr. Mendler does a very good job of answering questions and communicating. Regarding my situation with [...], I understand his interest in having me live a few months longer, but am not convinced that the benefit outweighs the cost.

Jan 10, 2025

5.0 stars

Dr. Mendler was very compassionate

Jan 10, 2025

5.0 stars

Dr Mendler and Dr Love are both wonderful! I felt very heard and supported.

Nov 25, 2024

5.0 stars

Dr. Mendler and I had a great conversation about my condition. He explained what he felt were the challenges my disease has and where we are now.He listened to my concerns and I felt that he valued my input and the plan that has been put in place was mutually acceptable.

Nov 15, 2024

5.0 stars

I'm welcomed like a family member into this office

Nov 11, 2024

5.0 stars

I felt confident that the physician knew my record and understood my case and had a resolution

Oct 16, 2024

5.0 stars

They handle complex case with caring and dispatch

Sep 25, 2024

5.0 stars

Dr Mendler was not only supportive but was totally upbeat about my response to treatment. His positive attitude helped relieve my anxiety.

Sep 25, 2024

4.6 stars

He is very empathetic.

Sep 01, 2024

5.0

Dr Mendler has been a blessing to me during this difficult time in my life. I can't thank him enough, and also Shaun, for their expertise and commitment to my care.

Aug 31, 2024

5.0

Dr Mendler has taken the time to know me and my opinions. . To have a caring,knowledgeable Dr.,is comforting. We live in [...],wouldn't be treated by any other centerpositive it's the best place.

Aug 24, 2024

4.0

No problem all were very helpful

Aug 24, 2024

5.0

Dr Mendler is maybe the best Dr I have engaged with. I ask lots of questions. Some are very complicated like my illness is. Dr Mendler has always answered any questions I have ever had in detail. That's what I need, Detail and being thorough with his explanations. I need facts and that's what I get. He is obviously exceptionally smart, and I feel blessed to have him as my care provider.

Aug 22, 2024

5.0

Very good

Aug 15, 2024

5.0

Dr. Mendler is [...] good communicator and is patient with questions. He looks and discusses overall care issues. Very fortunate to have him for a practitioner!

Jul 10, 2024

5.0

It is good to have a provider that also has normal health concerns and is able to relate through shared experiences.

Jun 08, 2024

5.0

The Dr. Is the best around

Mar 29, 2024

5.0

A very good communicator

Mar 23, 2024

3.8

There is so little known about VEXAS and treatment, but Dr. Mendler and Richardson are learning while guiding and much appreciated.

Mar 08, 2024

Dr. Jason Mendler is very knowledgeable and personable

Feb 16, 2024

5.0

Bedside manor was amazing. Made me feel comfortable about discussing my cancer.

Feb 04, 2024

5.0

Was the most through Dr I ever had

Feb 03, 2024

5.0

Dr. Mendler was very good

Dec 23, 2023

5.0

He is excellent in every way.

Dec 03, 2023

5.0

He was fabulous..

Nov 15, 2023

5.0

Can't say enough good about Dr. Mendler! He is excellent overall and we are thankful for his expertise and his relational skills.

Oct 27, 2023

4.6

Dr. Mendler was very approachable, listened well, and responded with what he knows - and what we still need to determine.

Aug 28, 2023

5.0

Provider is straight forward and direct with inquiries & directions; makes patient comfortable with understanding of diagnosis & treatment plans

Aug 09, 2023

5.0

Loved Dr. Mendler. He was fantastic. He explained everything and took as much time as we needed also great PR

Jul 26, 2023

5.0

Very pleasant experience. Did not feel rushed. All questions/concerns addressed.

Apr 10, 2023

5.0

Dr. Mendler made a difficult appointment a lot easier in his approach.

Apr 04, 2023

5.0

Again, the physician provider was outstanding by any measure and the Wilmot Cancer Institute Is fortunate to have him on their clinical team.

Mar 23, 2023

5.0

Provider was very knowledgeable about my condition & caring, compassionate.

Mar 07, 2023

5.0

Very good consultation.

Feb 13, 2023

5.0

Dr. Mendler couldn't have been more caring or responsive. He was everything a care provider should be. IThe scale doesn't go high enough to grade his level of care.

Jan 27, 2023

Very happy with the diagnosis and monitoring of my treatments. Dr Mendler was outstanding

Jan 26, 2023

5.0

He was honest even when we didn't like to hear it.... We appreciate being able to have an appt. every 6 mo. instead of oftener, as trips to Rochester are expensive.

Jan 25, 2023

5.0

Dr. Mendler treats me like family.

Nov 21, 2022

5.0

The provider was very good [...].

Oct 20, 2022

5.0

Dr. Mendler is caring, knowledgeable & willing to listen consistently.

Oct 19, 2022

5.0

Have great confidence in Dr. Mendler.

Oct 19, 2022

5.0

Dr. Mendler has a very calm, casual, engaging demeanor. He throughly explains what he believes to be your condition, tests that could clarify your current condition, and treatment options that might be pursued depending upon the outcome of additional tests.

Jul 27, 2022

5.0

He is very professional but listens to my input and clarifies questions very well

Jul 05, 2022

5.0

The team I have dealt with has answered all of my questions, discussed treatment and condition at length. Beyond what I ask. I have received excellent care - which is why I drive to Rochester [...]

Jun 14, 2022

5.0

Dr. Mendler is an excellent hematologist and physician

Apr 10, 2022

5.0

An excellent doctor!

Mar 18, 2022